Keywords: Bristol-Myers Squibb, Yervoy, Skli cancerm Malignant melanoma, UK. NICE

UK’s NICE negative on Bristol-Myers skin cancer drug Yervoy

Article | 14 October 2011

Print This

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has issued new draft guidance which recommends against ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in